DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.

Raleigh D, Liu SJ, Majd N, Zou C, Congivaram H, Najem H, Youngblood M, Wang IC, Sengelmann S, Raval K, Jiang J, Foster K, Casey-Clyde T, Pak J, Pan S, Payne E, Lin K, Vasudevan H, Thompson M, Ozawa T, Mirchia K, Berger M, Weiss W, Heimberger A, de Groot J, Gilbert L

Open source

DOI: 10.21203/rs.3.rs-9657955/v1
Published: 2026 Jun 5
Container: Research square
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-9657955/v1,
  title = {DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.},
  author = {Raleigh D and Liu SJ and Majd N and Zou C and Congivaram H and Najem H and Youngblood M and Wang IC and Sengelmann S and Raval K and Jiang J and Foster K and Casey-Clyde T and Pak J and Pan S and Payne E and Lin K and Vasudevan H and Thompson M and Ozawa T and Mirchia K and Berger M and Weiss W and Heimberger A and de Groot J and Gilbert L},
  year = {2026},
  journal = {Research square},
  doi = {10.21203/rs.3.rs-9657955/v1},
  url = {https://doi.org/10.21203/rs.3.rs-9657955/v1}
}

RIS

TY  - JOUR
TI  - DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.
AU  - Raleigh D
AU  - Liu SJ
AU  - Majd N
AU  - Zou C
AU  - Congivaram H
AU  - Najem H
AU  - Youngblood M
AU  - Wang IC
AU  - Sengelmann S
AU  - Raval K
AU  - Jiang J
AU  - Foster K
AU  - Casey-Clyde T
AU  - Pak J
AU  - Pan S
AU  - Payne E
AU  - Lin K
AU  - Vasudevan H
AU  - Thompson M
AU  - Ozawa T
AU  - Mirchia K
AU  - Berger M
AU  - Weiss W
AU  - Heimberger A
AU  - de Groot J
AU  - Gilbert L
PY  - 2026
JO  - Research square
DO  - 10.21203/rs.3.rs-9657955/v1
UR  - https://doi.org/10.21203/rs.3.rs-9657955/v1
ER  -

APA

D, R., SJ, L., N, M., C, Z., H, C., H, N., M, Y., IC, W., S, S., K, R., J, J., K, F., T, C., J, P., S, P., E, P., K, L., H, V., M, T., T, O., K, M., M, B., W, W., A, H., J, D. G., & L, G. (2026). DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.. Research square. https://doi.org/10.21203/rs.3.rs-9657955/v1

Source records

pubmed · retrieved 2026-09-25T20:47:00.848Z